Heart rate variability biofeedback
Heart rate variability biofeedback has been studied in 7 papers since 2022: 4 trials in people, 2 reviews. The newest paper, Dec 3, 2024: “Heart Rate Variability, Hypnosis, and Psychotherapy”.
7 papers study it2 findingsUpdated
See all 7 papers on heart rate variability biofeedback
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“There were also opposing effects of the Osc+ and Osc- interventions on tTau for younger adults and pTau-181 for older adults.”
- 1 lab in 1 country
- Funders: National Institute on Aging and 1 more
- Human trial4
What did studies of heart rate variability biofeedback find?
1Studies of heart rate variability biofeedback measured one outcome, clinical outcomes in coronary heart disease, pain, and hypertension.
Clinical outcomes in coronary heart disease, pain, and hypertension
upin humans1
1 study
Clinical outcomes in coronary heart disease, pain, and hypertension
upin humans1
Heart rate variability biofeedback improves clinical outcomes in coronary heart disease, pain, and hypertension in humans (coronary heart disease, pain, and hypertension).
“Generally, the levels of evidence for the benefits of HRV-B is high in CHD, pain, and hypertension, moderate in cancer, and poor in diabetes and dementia.”
Reviewcoronary heart disease, pain, and hypertension
Neuromodulation Applied to Diseases: The Case of HRV Biofeedback
Journal of clinical medicine
What is heart rate variability biofeedback linked with?
1Studies link heart rate variability biofeedback with phosphorylated tau 181.
Phosphorylated tau 181
mixedin humans1
1 study
Phosphorylated tau 181
mixedin humans1
Heart rate variability biofeedback is associated with phosphorylated tau 181 in humans.
“There were also opposing effects of the Osc+ and Osc- interventions on tTau for younger adults and pTau-181 for older adults.”
Human trial4 weeksn = 108
Scientific reports